19:21:01 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for March 20, 2015

2015-03-20 21:03 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added 3.41 points to 670.50 Friday, ending the week up 5.90 points. Murray Sinclair and Brian Bayley's halted capital pool shell, Kirkcaldy Capital Corp. (KRK), plans to complete its acquisition of Tigris Resources Ltd. on or about April 17. It has scheduled an April 14 meeting to ask shareholders to approve the deal.

Kirkcaldy plans to roll back its shares 1:2, leaving it with 2,006,300 postconsolidated shares, and then issue 35,177,800 postconsolidated shares to the shareholders of Tigris, after which the shell will change its name to Royal Road Minerals Ltd., symbol RYR. The largest shareholder of both the shell and its target is Sprott Inc. (SII: $2.80), which will indirectly own a total of 9,977,750 shares through Exploration Capital 2006 LP and Exploration Capital 2012 LP when the QT closes.

Tigris owns copper-gold properties in Turkey. Its main property is the Pertek project -- pertek means tiny fortress in Armenian -- in southeastern Turkey. The company's chief executive officer, Dr. Timothy Coughlin, will become CEO of Kirkcaldy with an annual salary of $172,000 when the QT closes. He will own 1,131,083 shares. Dr. Coughlin is a geologist who co-founded and managed Lydian International Ltd. (LYD: $0.52) until early last year, when he resigned to focus on Tigris. Lydian is a gold company with a project in Armenia, Turkey's neighbour. The stock traded up to $3.21 in 2011 when Dr. Coughlin was president. Before Lydian, Dr. Coughlin was the chief geologist at AngloGold Ashanti Ltd. (AU: $9.84 (U.S.)).

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed